XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity Attributable to Acushnet Holdings Corp.
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Tax
Retained Earnings
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021     75,855          
Beginning balance at Dec. 31, 2021 $ 1,080,267 $ 1,042,844 $ 76 $ 948,423 $ (99,582) $ 324,966 $ (131,039) $ 37,423
Changes in stockholders' equity                
Net income 82,026 81,045       81,045   981
Other comprehensive loss (4,945) (4,945)     (4,945)      
Share-based compensation 5,189 5,189   5,189        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     434          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (10,373) (10,373)   (10,373)        
Purchases of common stock (Note 10) (29,894) (29,894)         (29,894)  
Dividends and dividend equivalents declared (13,473) (13,473)       (13,473)    
Dividends declared to noncontrolling interests (101)             (101)
Ending balance (in shares) at Mar. 31, 2022     76,289          
Ending balance at Mar. 31, 2022 1,108,696 1,070,393 $ 76 943,239 (104,527) 392,538 (160,933) 38,303
Beginning balance (in shares) at Dec. 31, 2021     75,855          
Beginning balance at Dec. 31, 2021 1,080,267 1,042,844 $ 76 948,423 (99,582) 324,966 (131,039) 37,423
Changes in stockholders' equity                
Dividends and dividend equivalents declared (53,051)              
Ending balance (in shares) at Dec. 31, 2022     76,322          
Ending balance at Dec. 31, 2022 976,703 939,056 $ 76 960,685 (109,668) 473,130 (385,167) 37,647
Changes in stockholders' equity                
Sale of equity to noncontrolling interests 264 264   444   (180)    
Net income 93,654 93,275       93,275   379
Other comprehensive loss (4,011) (4,011)     (4,011)      
Share-based compensation 7,119 7,119   7,119        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     447          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (11,413) (11,413) $ 1 (11,414)        
Purchases of common stock (Note 10) (23,539) (23,539)         (23,539)  
Dividends and dividend equivalents declared (13,629) (13,629)       (13,629)    
Ending balance (in shares) at Mar. 31, 2023     76,769          
Ending balance at Mar. 31, 2023 $ 1,025,148 $ 987,122 $ 77 $ 956,834 $ (113,679) $ 552,596 $ (408,706) $ 38,026